BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 18334114)

  • 1. Correlation of -31G/C polymorphisms of survivin promoter to tumorigenesis of gastric carcinoma.
    Cheng ZJ; Hu LH; Huang SJ
    Ai Zheng; 2008 Mar; 27(3):258-63. PubMed ID: 18334114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Correlation of XPC Ala499Val and Lys939Gln polymorphisms to risks of esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma].
    Zhou RM; Li Y; Wang N; Zhang XJ; Dong XJ; Guo W
    Ai Zheng; 2006 Sep; 25(9):1113-9. PubMed ID: 16965652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Association of polymorphisms of p21cip1 and p27kip1 genes with susceptibilities of esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma].
    Guo W; Cui YJ; Fang SM; Li Y; Wang N; Zhang JH
    Ai Zheng; 2006 Feb; 25(2):194-9. PubMed ID: 16480585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between survivin gene promoter -31 C/G polymorphism and urothelial carcinoma risk in Taiwanese population.
    Wang YH; Chiou HY; Lin CT; Hsieh HY; Wu CC; Hsu CD; Shen CH
    Urology; 2009 Mar; 73(3):670-4. PubMed ID: 19038421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of stromal cell-derived factor-1 and survivin gene polymorphisms on gastric cancer risk.
    Liarmakopoulos E; Theodoropoulos G; Vaiopoulou A; Rizos S; Aravantinos G; Kouraklis G; Nikiteas N; Gazouli M
    Mol Med Rep; 2013 Mar; 7(3):887-92. PubMed ID: 23258739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Correlation of E-cadherin polymorphisms to esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma].
    Zhang XF; Wang YM; Wang R; Wei LZ; Li Y; Guo W; Wang N; Zhang JH
    Ai Zheng; 2005 May; 24(5):513-9. PubMed ID: 15890089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association between the survivin -31G/C promoter polymorphism and hepatocellular carcinoma risk in a Turkish population.
    Bayram S; Akkız H; Bekar A; Akgöllü E
    Cancer Epidemiol; 2011 Dec; 35(6):555-9. PubMed ID: 21296634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survivin promoter polymorphism and cervical carcinogenesis.
    Borbély AA; Murvai M; Szarka K; Kónya J; Gergely L; Hernádi Z; Veress G
    J Clin Pathol; 2007 Mar; 60(3):303-6. PubMed ID: 16714396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Association of single nucleotide polymorphism at interleukin-10 gene 1082 nt with the risk of gastric cancer in Chinese population].
    Zhou SZ; Zhu WL; Li MY; Li HY; Zhang JR
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(8):1335-8. PubMed ID: 18753053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single nucleotide polymorphisms in the promoter region of the E-cadherin gene in gastric cancer: case-control study in a young Mexican population.
    Medina-Franco H; Ramos-De la Medina A; Vizcaino G; Medina-Franco JL
    Ann Surg Oncol; 2007 Aug; 14(8):2246-9. PubMed ID: 17549573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of a single nucleotide polymorphism in the E-cadherin gene promoter with tumorigenesis and progression of gastric carcinoma in Japan.
    Kuraoka K; Oue N; Yokozaki H; Kitadai Y; Ito R; Nakayama H; Yasui W
    Int J Oncol; 2003 Aug; 23(2):421-7. PubMed ID: 12851691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative analysis of apoptosis-related gene expression in hepatocellular carcinoma.
    Ikeguchi M; Hirooka Y; Kaibara N
    Cancer; 2002 Nov; 95(9):1938-45. PubMed ID: 12404288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Correlations of polymorphisms in matrix metalloproteinase-3 and -7 promoters to susceptibility to brain astrocytoma].
    Lu ZQ; Wang YM; Cao YY; Zhang QJ; Zhang XH; Li YH; Wang HS; Xie HL; Jiao BH; Zhang JH
    Ai Zheng; 2007 May; 26(5):463-8. PubMed ID: 17672933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Correlation of matrix metalloproteinase-3 polymorphism to genetic susceptibility and lymph node metastasis of non-small cell lung cancer].
    Fang SM; Jin X; Li Y; Wang R; Guo W; Wang N; Zhang JH
    Ai Zheng; 2005 Mar; 24(3):305-10. PubMed ID: 15757531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of interindividual differences in p14ARF promoter methylation with single nucleotide polymorphism in primary colorectal cancer.
    Kang MY; Lee BB; Ji YI; Jung EH; Chun HK; Song SY; Park SE; Park J; Kim DH
    Cancer; 2008 Apr; 112(8):1699-707. PubMed ID: 18327804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inducible nitric oxide synthase gene promoter polymorphism is associated with increased gastric mRNA expression of inducible nitric oxide synthase and increased risk of gastric carcinoma.
    Kaise M; Miwa J; Suzuki N; Mishiro S; Ohta Y; Yamasaki T; Tajiri H
    Eur J Gastroenterol Hepatol; 2007 Feb; 19(2):139-45. PubMed ID: 17272999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
    Wang R; Wang X; Li B; Lin F; Dong K; Gao P; Zhang HZ
    Breast Cancer Res Treat; 2009 Sep; 117(1):45-54. PubMed ID: 18791823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No evidence of correlation between the single nucleotide polymorphism of DNMT3B promoter and gastric cancer risk in a Japanese population.
    Aung PP; Matsumura S; Kuraoka K; Kunimitsu K; Yoshida K; Matsusaki K; Nakayama H; Yasui W
    Oncol Rep; 2005 Nov; 14(5):1151-4. PubMed ID: 16211278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastric cancer risk predisposition and prognostic significance of vascular endothelial growth factor (VEGF) gene polymorphisms--a case-control study in an Omani population.
    Al-Moundhri MS; Al-Nabhani M; Burney IA; Al-Farsi AA; Al-Bahrani B
    Mol Carcinog; 2009 Dec; 48(12):1170-6. PubMed ID: 19676106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of survivin on cell proliferation and apoptosis in gastric cancer.
    Wakana Y; Kasuya K; Katayanagi S; Tsuchida A; Aoki T; Koyanagi Y; Ishii H; Ebihara Y
    Oncol Rep; 2002; 9(6):1213-8. PubMed ID: 12375022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.